Internal Medicine, Pulmonary Disease · Kearny, NJ
NPI
1164480372
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
744 Kearny Ave
Kearny, NJ, 07032
Phone (201) 991-4544
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
24,919 services
Medicare patients, 2024
1,155
Average age 75
Drug cost, 2024
$8.1M
26,024 prescriptions
Company payments, 2025
$4,278
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jehad E Saliba was code 99490 (chronic, principal, and transitional care management), 3,462 times for 413 patients. In total Jehad E Saliba billed 24,919 services in 84 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 3,462 | 413 | $53.79 | $186K |
| 99214 Office E&M - Established | Office | 2,717 | 872 | $103.30 | $281K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,680 | 52 | $0.10 | $270 |
| 99457 E&M - Miscellaneous | Office | 2,635 | 293 | $42.45 | $112K |
| 99232 Hospital E&M - Subsequent | Facility | 2,209 | 232 | $66.45 | $147K |
| 99454 E&M - Miscellaneous | Office | 1,498 | 202 | $42.75 | $64K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,099 | 548 | $13.65 | $15K |
| 99497 Care Management/Coordination | Office | 489 | 470 | $65.62 | $32K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 464 | 464 | $141.85 | $66K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 456 | 456 | $21.07 | $9,606 |
| 99233 Hospital E&M - Subsequent | Facility | 442 | 64 | $99.76 | $44K |
| 94060 Pulmonary Function Testing | Office | 439 | 263 | $33.37 | $15K |
| 96116 Behavioral Health Services | Office | 407 | 379 | $73.72 | $30K |
| G0008 Administration of influenza virus vaccine | Office | 350 | 326 | $35.50 | $12K |
| 96127 Behavioral Health Services | Office | 341 | 169 | $4.01 | $1,367 |
By year: 2022 $1.0M for 16,174 services; 2023 $1.4M for 21,009 services; 2024 $1.4M for 24,919 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87502 Infectious Agent Detection by DNA/RNA | 115 | 105 | $93.88 | $11K |
| 87635 COVID Specific | 115 | 102 | $50.28 | $5,782 |
| 87634 Infectious Agent Detection by DNA/RNA | 97 | 87 | $68.80 | $6,674 |
| 82043 Clinical Chemistry | 43 | 42 | $5.66 | $243 |
| 81003 Clinical Chemistry | 19 | 19 | $2.20 | $41.8 |
| 87651 Infectious Agent Detection by DNA/RNA | 17 | 16 | $34.39 | $585 |
Medicare prescription drug claims, 2024
In 2024, the drug Jehad E Saliba prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,491 prescriptions and refills. In total Jehad E Saliba wrote 26,024 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,491 | 3,506 | 407 | $17K |
| Prednisone Generic | 974 | 1,094 | 536 | $1,982 |
| Metformin Hcl Generic | 869 | 2,237 | 278 | $6,280 |
| Pantoprazole Sodium Generic | 849 | 1,820 | 272 | $9,559 |
| Levothyroxine Sodium Generic | 679 | 1,634 | 179 | $8,421 |
| Losartan Potassium Generic | 630 | 1,571 | 195 | $5,883 |
| Amlodipine Besylate Generic | 626 | 1,461 | 177 | $4,045 |
| Metoprolol Succinate Generic | 619 | 1,427 | 185 | $8,528 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 596 | 819 | 182 | $18K |
| Rosuvastatin Calcium Generic | 577 | 1,525 | 194 | $9,384 |
| Alprazolam Generic | 551 | 569 | 113 | $2,725 |
| Jardiance Empagliflozin | 527 | 931 | 123 | $515K |
| Eliquis Apixaban | 406 | 492 | 59 | $189K |
| Azithromycin Generic | 360 | 478 | 256 | $2,892 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 351 | 451 | 82 | $279K |
Brand drugs: 5,169 claims; generic drugs: 20,705 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jehad E Saliba $4,278 ($4,278 in general payments such as food, travel and fees) from 34 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,122.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 46 | $1,122 |
| GlaxoSmithKline, LLC. GSK | 25 | $603 |
| Novo Nordisk Inc NVO | 30 | $529 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $302 |
| Genzyme Corporation SNY | 10 | $270 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 8 | $146 |
| Pfizer Inc. PFE | 8 | $145 |
| Lilly USA, LLC LLY | 7 | $121 |
| Exact Sciences Corporation EXAS | 4 | $99.73 |
| Axsome Therapeutics, Inc. AXSM | 5 | $85.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.